Found 62 matching trials
Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy PHASE2 This study is a prospective, open-label, single-arm phase II clinical trial...
Show More Location
First Affiliated Hospital of Nanjing Medical Unviersity
Learn More & Join Trial
Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma PHASE2 dMMR/MSI-H is a key molecular subtype of gastric cancer, found in 8-22% of ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma. PHASE2 Recently, a number of clinical studies were carried out to evaluate the the...
Show More Location
Multiple Locations
Learn More & Join Trial
the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer NA To evaluate the clinical efficacy (safety, feasibility and long-term effica...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
D2 Versus D1 Gastrectomy of Operable Gastric Cancer N/A Surgery is the mainstay treatment of operable gastric carcinoma but the opt...
Show More Location
Multiple Locations
Learn More & Join Trial
Expanded Indications of Endoscopic Submucosal Dissection for Early Gastric Cancer in China N/A Background: The main treatment methods for early gastric cancer (EGC) inclu...
Show More Location
Beijing Friendship hospital
Learn More & Join Trial
Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric Cancer NA The purpose of this study is to evaluate the effect and safety of laparosco...
Show More Location
Department of Minimally Invasive Gastrointestinal Surgery, Peking University Cancer Hospital & Institute
Learn More & Join Trial
Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma PHASE2 The effective treatment of G/GEJ adenocarcinoma has always been a research ...
Show More Location
Xijing Hospital of Digestive Diseases
Learn More & Join Trial
Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study PHASE2 This is a phase II open-label study to evaluate the efficacy and safety of ...
Show More Location
Xijing Hospital, Air Force Medical University
Learn More & Join Trial
SP Intravenous Chemotherapy Versus SP by HIPEC in Stage โ
ข Patients After D2 Gastrectomy PHASE3 The study is designed to assess the safety and efficacy of S-1 plus cisplat...
Show More Location
IEC of Insititution for National Drug Clinical Trials,Tangdu Hospital,Fourth Military Medical University
Learn More & Join Trial